68Ga-PSMA PET/CT in Hepatic Metastasis From Pancreatic Neuroendocrine Tumor

From the ∗Department of Nuclear Medicine, the First Affiliated Hospital, Fujian Medical University

†Department of Nuclear Medicine, National Regional Medical Center, Binhai Campus, the First Affiliated Hospital, Fujian Medical University

‡Fujian Provincial Key Laboratory of Precision Medicine for Cancer, the First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian Province, China.

Received for publication June 19, 2023; revision accepted July 12, 2023.

S.C. and Z.L. contributed equally to this work.

Funding information: This study was funded by the National Natural Science Foundation of China (81971651) and Scientific Research Project from the Education Department of Fujian Province (JAT210089).

Compliance with ethical standards: The study was approved by the institutional review board of our hospital, and written informed consent for publication of this report was obtained from the patient.

Conflicts of interest and sources of funding: none declared.

Correspondence to: Weibing Miao, MD, PhD, Department of Nuclear Medicine, The First Affiliated Hospital of Fujian Medical University, No. 20 Chazhong Rd, Taijiang District, Fuzhou 350005, China. E-mail: [email protected].

Comments (0)

No login
gif